Review





Similar Products

t84.1  (InVivo BioTech Services)
90
InVivo BioTech Services t84.1
B cell aggregation was induced by 16 h of incubation with anti-CD19 ( A , compare untreated to anti-CD19-treated cells). ( B – D ) Inhibition of CD19-induced B cell aggregation by the anti-CEACAM1 antibody clones C5-1X (150 μg/ml) ( B ), 4D1/C2 (150 μg/ml) ( C ) and <t>T84.1</t> (150, 250 vs . 400 μg/ml) ( D ). B cells were isolated from n = 3 ( B,C ) or n = 9 ( D ) healthy donors, respectively. ( E ) Induction of B cell aggreation by anti-CD19 antibody and its inhibition by T84.1 in age- and gender-matched MS patients ( n = 4) and healthy controls ( n = 4).
T84.1, supplied by InVivo BioTech Services, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/t84%2E1/pmc04951702-241-11-12?v=InVivo+BioTech+Services
Average 90 stars, based on 1 article reviews
t84.1 - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
t84.1 antibodies  (Eppendorf AG)
90
Eppendorf AG t84.1 antibodies
B cell aggregation was induced by 16 h of incubation with anti-CD19 ( A , compare untreated to anti-CD19-treated cells). ( B – D ) Inhibition of CD19-induced B cell aggregation by the anti-CEACAM1 antibody clones C5-1X (150 μg/ml) ( B ), 4D1/C2 (150 μg/ml) ( C ) and <t>T84.1</t> (150, 250 vs . 400 μg/ml) ( D ). B cells were isolated from n = 3 ( B,C ) or n = 9 ( D ) healthy donors, respectively. ( E ) Induction of B cell aggreation by anti-CD19 antibody and its inhibition by T84.1 in age- and gender-matched MS patients ( n = 4) and healthy controls ( n = 4).
T84.1 Antibodies, supplied by Eppendorf AG, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/t84%2E1/pm22463104-294-24-20?v=Eppendorf+AG
Average 90 stars, based on 1 article reviews
t84.1 antibodies - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
alexa 546 conjugated monoclonal antibody t84.1  (Thermo Fisher)
90
Thermo Fisher alexa 546 conjugated monoclonal antibody t84.1
B cell aggregation was induced by 16 h of incubation with anti-CD19 ( A , compare untreated to anti-CD19-treated cells). ( B – D ) Inhibition of CD19-induced B cell aggregation by the anti-CEACAM1 antibody clones C5-1X (150 μg/ml) ( B ), 4D1/C2 (150 μg/ml) ( C ) and <t>T84.1</t> (150, 250 vs . 400 μg/ml) ( D ). B cells were isolated from n = 3 ( B,C ) or n = 9 ( D ) healthy donors, respectively. ( E ) Induction of B cell aggreation by anti-CD19 antibody and its inhibition by T84.1 in age- and gender-matched MS patients ( n = 4) and healthy controls ( n = 4).
Alexa 546 Conjugated Monoclonal Antibody T84.1, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/t84%2E1/10__1074_slash_jbc__m610903200-94-2-4?v=Thermo+Fisher
Average 90 stars, based on 1 article reviews
alexa 546 conjugated monoclonal antibody t84.1 - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
ceacam1 antibodies t84.1  (R&D Systems)
90
R&D Systems ceacam1 antibodies t84.1
B cell aggregation was induced by 16 h of incubation with anti-CD19 ( A , compare untreated to anti-CD19-treated cells). ( B – D ) Inhibition of CD19-induced B cell aggregation by the anti-CEACAM1 antibody clones C5-1X (150 μg/ml) ( B ), 4D1/C2 (150 μg/ml) ( C ) and <t>T84.1</t> (150, 250 vs . 400 μg/ml) ( D ). B cells were isolated from n = 3 ( B,C ) or n = 9 ( D ) healthy donors, respectively. ( E ) Induction of B cell aggreation by anti-CD19 antibody and its inhibition by T84.1 in age- and gender-matched MS patients ( n = 4) and healthy controls ( n = 4).
Ceacam1 Antibodies T84.1, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/t84%2E1/pm16568082-50-6-15?v=R%26D+Systems
Average 90 stars, based on 1 article reviews
ceacam1 antibodies t84.1 - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
alexa-546 conjugated mab t84.1  (Thermo Fisher)
90
Thermo Fisher alexa-546 conjugated mab t84.1
B cell aggregation was induced by 16 h of incubation with anti-CD19 ( A , compare untreated to anti-CD19-treated cells). ( B – D ) Inhibition of CD19-induced B cell aggregation by the anti-CEACAM1 antibody clones C5-1X (150 μg/ml) ( B ), 4D1/C2 (150 μg/ml) ( C ) and <t>T84.1</t> (150, 250 vs . 400 μg/ml) ( D ). B cells were isolated from n = 3 ( B,C ) or n = 9 ( D ) healthy donors, respectively. ( E ) Induction of B cell aggreation by anti-CD19 antibody and its inhibition by T84.1 in age- and gender-matched MS patients ( n = 4) and healthy controls ( n = 4).
Alexa 546 Conjugated Mab T84.1, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/t84%2E1/10__1074_slash_jbc__m309115200-112-23-21?v=Thermo+Fisher
Average 90 stars, based on 1 article reviews
alexa-546 conjugated mab t84.1 - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

Image Search Results


B cell aggregation was induced by 16 h of incubation with anti-CD19 ( A , compare untreated to anti-CD19-treated cells). ( B – D ) Inhibition of CD19-induced B cell aggregation by the anti-CEACAM1 antibody clones C5-1X (150 μg/ml) ( B ), 4D1/C2 (150 μg/ml) ( C ) and T84.1 (150, 250 vs . 400 μg/ml) ( D ). B cells were isolated from n = 3 ( B,C ) or n = 9 ( D ) healthy donors, respectively. ( E ) Induction of B cell aggreation by anti-CD19 antibody and its inhibition by T84.1 in age- and gender-matched MS patients ( n = 4) and healthy controls ( n = 4).

Journal: Scientific Reports

Article Title: CEACAM1 mediates B cell aggregation in central nervous system autoimmunity

doi: 10.1038/srep29847

Figure Lengend Snippet: B cell aggregation was induced by 16 h of incubation with anti-CD19 ( A , compare untreated to anti-CD19-treated cells). ( B – D ) Inhibition of CD19-induced B cell aggregation by the anti-CEACAM1 antibody clones C5-1X (150 μg/ml) ( B ), 4D1/C2 (150 μg/ml) ( C ) and T84.1 (150, 250 vs . 400 μg/ml) ( D ). B cells were isolated from n = 3 ( B,C ) or n = 9 ( D ) healthy donors, respectively. ( E ) Induction of B cell aggreation by anti-CD19 antibody and its inhibition by T84.1 in age- and gender-matched MS patients ( n = 4) and healthy controls ( n = 4).

Article Snippet: The three clones C5-1X (Reliatech), 4D1/C2 (produced and purified in-house) and T84.1 (inVivo BioTech Services) were tested at different concentrations (150 μg/ml, 250 μg/ml and 400 μg/ml).

Techniques: Incubation, Inhibition, Clone Assay, Isolation